US equities |
MU $941.87 ▼-4.77% META $764.29 ▲+2.87% NVDA $227.99 ▲+0.74% SNDK $1,455.70 ▼-2.13% MSFT $545.50 ▲+0.80% AAPL $341.22 ▲+0.07% SPCX $156.87 ▼-4.01% AMD $600.87 ▲+1.11%
FinancialContent

MiniMed Group, Inc. - Common Stock (NQ:MMED)

18.68 -0.12 (-0.66%)
Delayed Quote Updated: 3:31 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MiniMed Group, Inc. - Common Stock

News headline image
Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There? ↗
The medical device giant deserves a lot more attention. 
Via The Motley Fool
Topics Economy
News headline image
Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in October ↗
AbbVie and Medtronic are both stable blue chip dividend plays in this choppy market. 
Via The Motley Fool
Topics Bonds Economy Intellectual Property
News headline image
Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway? ↗
The medical device giant grew its top line by a double-digit percentage in the first quarter of its fiscal 2027. 
Via The Motley Fool
News headline image
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors? ↗
Medtronic implemented its 49th consecutive annual dividend increase in June. 
Via The Motley Fool
News headline image
MiniMed (MMED) Q1 2027 Earnings Call Transcript ↗
Flex pump launch drives 15.8% revenue growth and guidance raise. 
Via The Motley Fool
Topics Earnings
News headline image
Why MiniMed Stock Was Soaring This Week ↗
It easily topped analyst revenue estimates in its opening quarter of fiscal 2027. 
Via The Motley Fool
News headline image
4 Reasons to Buy Medtronic Stock Like There's No Tomorrow ↗
The medical device maker is on the cusp of a multi-year recovery. 
Via The Motley Fool
Topics Economy
News headline image
MiniMed Group Q1 Earnings Call Highlights ↗
MiniMed Group (NASDAQ:MMED) reported fiscal 2027 first-quarter revenue of $843 million, with organic revenue growth of 15.8%, as demand for its newer insulin-delivery and continuous glucose monitoring... 
Via MarketBeat
Topics Earnings
News headline image
Minimed Group Q1 2027 Earnings Call Transcript ↗
On Tuesday, Minimed Group (NASDAQ:MMED) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
News headline image
I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026 ↗
The medical device maker still has a bright future. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run ↗
Medtronic could finally be on the cusp of a long-awaited turnaround. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
5 Best Dividend Stocks to Own in Case the AI Trade Ends ↗
Even the hottest AI stocks won't win forever. Diversification is the key to long-term wealth. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Medtronic Bottoms, Healthy Rebound Ahead ↗
Medtronic is on track to reverse after a major market meltdown driven by fear. The upside potential is double-digit, not including the dividend. 
Via MarketBeat
News headline image
MiniMed Group Q4 Earnings Call Highlights ↗
MiniMed Group (NASDAQ:MMED) reported record fiscal 2026 revenue and outlined a slate of product launches it said will support faster growth in fiscal 2027, as management held the company’s first... 
Via MarketBeat
Topics Earnings Initial Public Offering
News headline image
3 Stocks With Monster Potential to Hold Through the Next Decade of Uncertainty ↗
These three stocks are deeply unloved, giving them material upside, and they have great businesses. 
Via The Motley Fool
Topics Economy
News headline image
Why Savvy Investors Are Loading Up on This Beaten-Down Stock ↗
Medtronic is closing in on Dividend King status, and its surgical robot is gaining traction. 
Via The Motley Fool
News headline image
The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot
As of April 3, 2026, Medtronic plc (NYSE: MDT) stands at a critical inflection point in its 77-year history. Once viewed as a lumbering healthcare conglomerate burdened by its own scale, the... 
Via Finterra
Topics Artificial Intelligence Initial Public Offering Product Recall